rfhg_21235.1

Basic information about the TSS

---

TSS ID: rfhg_21235.1 TSS ID(Version3): hg_9112.1 hg_9113.1 hg_9111.1 Species: human Chr: chr1		Start: 234373441 End: 234373581 Strand: +
Source datasets	FANTOM5|PRJNA401781|PRJNA597322|PRJNA4843412|DRA013844 |PRJNA548673|PRJNA615891|PRJDB5282
Protocol	CAGE|oligo_capping|STRIPE-seq|NETCAGE|RAMPAGE |ReCappable-seq|SLIC_CAGE|C1CAGE|TIF-seq2
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2292479,EH38E1433256)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000366615.10:0 ENST00000619305.1:0 BC052810:0 BC035925:0 GeneID: 388753 HGNC/MGI_ID: HGNC:18025 UniProt_ID: Q5JTJ3 Nearer transcript ids and distances: ENST00000366613.1:102 NM_001012985.2:102 BC116455:102 ENST00000366612.1:120 NM_001301733.1:120 BC064905:120 BC025793:206 view more...

Gene_name: cytochrome c oxidase assembly factor 6 Gene_symbol: COA6 Gene_synonyms: Gene_source: HGNC:18025

TATA-Box annotation

---

Distance to TSS:	55
Nearest PromoterID:	NM_001206641
Entrez ID:	388753
Nearest Unigene:	Hs.23198
Nearest Refseq:	NM_001012985
Nearest Ensembl:	ENSG00000168275
Gene Name:	cytochrome c oxidase assembly factor 6
Gene Alias:	C1orf31|CEMCOX4
Gene Type:	protein-coding
CpG%:	0.078571
GC%:	0.588652
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@COA6 p2@COA6 p3@COA6 p4@COA6 p5@COA6 p6@COA6 p7@COA6
Sample		p1@COA6	p2@COA6	p3@COA6	p4@COA6	p5@COA6	p6@COA6	p7@COA6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	72.27	15.97	4.87	4.09	1.36	2.34	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	69.40	19.83	3.24	4.65	1.21	1.21	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	62.89	17.55	4.44	3.47	1.35	2.89	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	61.96	16.63	3.53	6.03	2.91	3.33	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	67.71	17.55	4.27	4.05	2.47	3.82	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	64.73	14.34	4.85	2.33	1.55	3.88	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	69.72	27.24	8.93	4.36	2.61	3.49	4.36
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	66.13	19.14	5.81	5.33	4.12	1.94	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.66	18.81	6.41	3.85	3.85	3.42	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	67.82	20.87	6.96	1.74	6.96	2.90	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	54.98	17.38	6.06	2.83	4.04	3.64	3.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	56.51	18.29	7.72	4.88	3.66	6.10	4.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	11.93	2.26	1.61	0.81	0.48	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.42	1.50	1.65	0.30	0.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.10	2.42	1.98	0.44	0.00	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.81	3.27	1.26	0.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.58	3.28	1.53	0.44	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.01	2.11	1.69	0.00	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	7.46	3.20	1.07	0.53	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.98	2.86	1.96	0.60	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.56	2.81	1.74	0.40	0.00	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	2.59	2.07	0.35	0.35	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.14	1.55	1.16	0.13	0.78	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.71	2.91	1.70	0.49	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.80	3.10	1.03	0.00	0.26	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	4.43	1.90	0.63	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	1.65	1.65	0.00	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.37	3.54	1.65	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.37	3.23	1.45	0.48	0.32	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.94	2.90	1.63	0.72	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.30	3.35	0.21	0.42	1.05	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.96	1.37	1.95	1.17	0.59	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	1.06	1.69	0.42	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.21	3.63	2.14	0.82	0.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.47	1.31	0.19	0.56	0.75	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.73	5.37	0.96	0.19	0.38	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.26	3.47	1.43	0.20	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.46	2.82	0.60	0.81	0.40	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.96	4.59	1.35	0.81	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.68	2.88	1.44	0.72	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.23	4.94	1.18	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.86	4.10	1.17	0.15	0.29	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.65	1.48	1.05	0.63	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.76	3.67	1.92	0.70	0.35	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.65	2.41	1.61	0.40	1.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.29	2.56	1.40	1.16	0.47	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.00	3.84	1.20	0.48	0.00	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.39	3.28	2.38	0.30	0.30	0.00	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	15.32	3.11	1.68	0.96	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.90	2.83	1.01	0.20	0.61	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.66	3.89	2.46	1.02	0.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.68	3.34	0.89	0.67	0.67	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	27.98	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.55	1.06	2.84	1.06	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.60	2.98	0.66	0.99	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	8.39	4.19	1.68	0.84	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.24	6.43	1.38	0.00	1.38	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.91	1.30	0.97	1.30	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	2.25	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.69	3.14	1.26	0.63	0.63	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	2.12	0.71	0.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.02	1.68	0.56	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	6.37	3.18	0.80	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.15	3.74	1.02	0.68	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.80	1.62	0.32	0.32	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.84	1.06	0.71	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	15.79	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	0.98	0.49	1.95	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.91	1.98	1.49	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	1.88	1.41	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.57	2.32	0.66	1.32	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	2.17	1.86	1.24	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.78	1.53	0.31	2.14	0.92	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	14.57	3.01	2.06	2.38	0.16	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	14.28	4.33	1.44	0.80	0.64	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	14.25	2.93	1.40	1.53	0.64	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	11.96	1.49	4.48	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	16.08	0.67	1.34	1.67	1.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	12.12	5.10	0.00	0.64	1.28	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	3.30	0.00	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	2.71	2.71	2.26	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.43	3.30	2.95	0.87	1.04	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	19.17	4.30	1.37	0.78	0.39	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	26.00	3.09	1.80	0.77	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	22.02	3.90	0.84	1.39	0.56	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	8.82	1.76	2.94	1.18	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	24.93	5.47	2.33	1.21	0.40	0.00	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	32.92	1.29	1.61	1.29	0.97	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	17.60	3.20	1.07	2.13	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	14.47	3.90	0.56	1.67	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	24.54	3.74	4.57	0.83	2.08	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	30.89	3.27	0.50	1.76	0.25	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	18.65	4.25	2.29	0.33	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	16.44	4.87	0.61	1.83	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	23.65	5.52	1.55	1.10	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	9.32	2.15	0.72	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	0.00	1.20	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.53	6.48	1.80	0.54	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	5.02	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.86	1.85	0.62	0.62	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	15.91	6.52	3.43	0.69	1.14	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	8.57	4.41	3.18	1.22	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	7.19	0.90	1.80	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.16	6.08	0.87	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	4.28	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.43	3.89	1.20	0.90	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	2.53	2.53	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	5.28	0.00	1.98	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.35	3.25	0.97	1.62	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	4.85	2.43	1.94	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	1.78	0.59	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.56	3.39	1.88	1.51	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	2.18	2.18	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	5.02	0.00	5.02	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.33	5.27	0.99	0.49	0.16	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	0.00	2.73	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.89	4.98	1.66	1.06	0.15	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	4.82	1.61	0.00	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.25	4.72	1.32	1.13	0.00	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.76	5.08	2.14	0.80	0.27	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	5.85	1.95	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.77	4.31	1.00	1.49	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	4.80	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.27	3.60	1.03	0.86	0.00	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.56	4.37	2.43	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.76	3.42	0.38	0.76	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	3.63	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.83	2.85	1.71	0.00	0.00	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.83	2.99	1.71	1.07	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.87	3.87	0.77	0.77	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.08	6.10	0.94	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.47	3.54	0.96	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	16.41	4.28	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	3.51	1.17	2.34	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.45	5.72	0.90	1.81	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	4.75	1.19	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.33	5.59	2.03	0.51	1.02	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.06	7.64	1.27	1.78	0.51	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	3.81	0.64	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	2.59	0.86	1.73	1.29	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.51	3.60	1.69	2.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.31	5.80	0.87	0.87	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	2.83	2.83	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.39	6.10	1.02	1.53	0.51	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.37	3.43	0.86	1.07	0.43	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.24	1.80	1.20	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	2.92	2.19	1.46	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.18	4.60	1.84	1.61	0.46	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.59	5.59	3.05	1.53	1.02	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.69	4.54	1.45	1.45	0.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	3.67	1.22	0.92	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.12	5.74	1.43	1.43	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.53	3.55	0.67	0.67	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	3.05	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	4.98	0.55	2.22	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.83	3.18	0.79	1.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.17	2.54	1.82	1.82	0.36	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	20.39	3.68	1.23	1.23	0.12	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	16.77	2.05	1.37	1.37	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	9.23	1.47	1.47	0.84	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	21.96	6.62	2.09	0.70	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	32.03	3.56	1.13	0.81	0.81	0.16	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	26.55	3.13	0.60	0.89	0.15	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	62.85	7.00	3.90	3.56	2.06	0.57	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	66.15	9.77	6.39	3.01	2.51	0.63	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	65.32	9.33	5.01	2.96	2.16	0.23	0.80
Basophils, donor1	12241-129G9	12.82	2.62	0.52	1.05	0.52	0.52	0.26
Basophils, donor2	12242-129H1	13.35	2.53	0.72	0.00	0.72	0.72	0.00
Basophils, donor3	12243-129H2	6.47	2.65	1.18	0.73	0.59	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	7.33	4.31	1.51	0.86	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	1.37	0.00	0.46	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	3.77	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.45	2.70	0.62	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	14.28	4.15	0.69	1.38	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.37	5.58	3.06	1.62	1.26	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	35.04	4.53	4.23	6.39	2.27	1.85	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	34.00	7.69	5.12	9.08	2.10	0.93	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.58	3.20	6.72	11.83	4.16	0.32	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.89	1.69	0.56	0.56	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	3.53	1.30	0.37	0.19	0.74	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	9.22	1.32	0.00	0.44	0.44	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	56.04	2.83	2.55	1.42	0.57	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.01	3.03	3.79	1.52	1.14	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	20.38	2.63	3.94	0.99	1.31	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	8.82	3.47	0.72	0.72	0.58	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	12.37	2.11	1.51	0.30	0.91	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	14.45	2.61	1.18	0.24	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.19	3.68	0.67	0.33	0.33	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.49	3.59	0.55	0.00	1.10	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.07	3.72	0.74	0.50	0.99	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.48	2.35	0.39	0.59	0.78	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.18	2.49	0.36	0.36	0.89	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.41	3.70	0.65	1.52	1.09	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.09	2.34	0.23	0.23	0.94	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.37	1.58	0.53	1.06	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	8.87	0.00	1.11	3.33	3.33	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.10	4.61	0.59	0.00	0.30	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.56	2.59	1.80	0.40	1.60	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	25.19	4.58	2.91	0.42	1.04	0.83	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.80	5.72	0.92	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.89	2.71	1.36	0.23	0.45	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	2.62	0.00	1.31	2.62	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.72	1.34	1.08	0.27	0.81	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.29	1.40	0.70	0.17	0.35	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	11.78	2.10	0.00	0.84	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.63	2.39	0.55	0.00	0.92	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.61	3.17	0.35	1.06	0.35	1.06	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	13.60	2.19	0.88	0.00	0.88	0.00	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.10	4.53	0.70	0.52	0.52	0.00	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	2.97	0.37	1.12	0.00	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.11	6.47	0.65	1.51	0.65	0.43	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.37	4.09	1.64	0.00	0.82	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.76	3.48	0.46	0.93	0.93	0.46	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.70	2.32	1.39	1.86	1.39	0.93	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	21.58	2.62	5.89	0.65	1.53	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	25.41	2.54	2.77	1.39	2.31	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	4.55	6.07	1.52	2.60	0.65	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	18.06	4.98	2.65	0.47	1.25	0.31	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	22.01	4.02	4.19	0.52	0.87	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	22.52	3.12	2.45	0.45	1.56	0.00	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	27.81	4.08	5.61	0.51	1.79	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	20.42	4.83	5.05	0.66	0.66	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	27.58	4.21	7.37	0.63	1.47	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	6.10	0.00	4.06	4.06	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.70	8.14	12.20	3.39	2.71	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	4.14	10.36	4.14	3.11	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	26.65	8.00	7.46	1.60	2.67	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	8.04	6.97	2.68	1.61	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.08	7.02	9.13	4.21	1.40	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	32.94	8.63	12.55	4.71	4.71	0.78	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	29.00	2.64	6.59	3.95	3.95	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	2.47	0.82	2.47	2.47	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	4.35	4.35	0.00	0.73	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	4.04	2.52	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	32.73	14.55	1.62	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	34.36	14.78	1.60	1.60	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	3.01	2.01	8.03	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.36	1.69	0.56	2.81	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.92	4.51	4.51	7.52	2.25	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	35.18	6.54	6.31	8.79	2.48	0.90	0.68
CD4+ T Cells, donor1	11225-116C1	13.93	3.93	0.71	1.07	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	12.25	1.84	0.61	1.22	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	16.16	2.13	0.61	0.91	0.30	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.67	5.87	5.87	4.08	2.04	0.00	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	29.42	5.39	6.96	3.59	0.90	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.88	9.20	6.61	4.60	3.16	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	17.54	9.01	9.01	2.37	3.79	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	26.69	7.73	9.83	2.81	4.21	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.99	7.66	3.76	3.03	2.17	0.14	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.50	8.81	3.22	3.39	1.19	0.34	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.24	7.90	3.71	3.71	2.10	0.00	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	25.10	8.52	4.03	3.59	0.90	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	28.30	9.08	7.34	2.10	1.75	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.88	7.04	5.72	3.52	2.64	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	17.71	7.17	2.95	1.69	1.26	0.00	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.68	10.39	4.36	5.19	1.45	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	33.41	9.36	2.34	2.34	2.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	17.95	7.07	4.08	1.09	0.82	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	23.58	10.18	4.82	3.22	1.61	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	21.52	7.17	1.79	3.59	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	27.44	8.34	5.01	2.41	2.41	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.76	7.36	2.82	3.25	2.60	0.22	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	35.10	8.62	2.52	3.78	1.26	0.21	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	29.83	10.11	2.02	3.54	3.54	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.93	13.86	6.07	3.03	2.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	24.41	10.90	3.92	4.36	1.74	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	50.48	15.84	9.90	4.45	6.43	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	43.39	10.16	8.31	5.54	6.46	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	8.37	12.56	6.98	9.77	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	32.95	8.31	5.54	1.94	1.11	0.00	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	37.30	9.32	7.36	5.64	1.96	0.25	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	46.20	12.32	6.16	3.08	7.70	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	41.90	7.88	6.80	3.94	3.94	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	44.32	19.39	6.92	9.69	5.54	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	8.18	0.98	0.98	0.98	0.00	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	7.51	1.13	3.75	0.75	0.38	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	9.85	2.52	1.01	0.76	0.76	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	30.05	6.42	2.29	4.82	1.61	0.69	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.83	5.51	1.68	3.83	0.96	0.72	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.00	6.29	2.19	2.46	1.64	0.00	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.62	7.21	1.80	6.30	0.60	1.50	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.92	6.72	2.16	2.16	0.72	1.20	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	29.56	3.41	1.36	4.32	2.05	0.23	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	36.29	8.69	2.39	3.91	0.87	1.09	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	39.48	5.53	1.32	1.32	0.53	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	41.74	3.28	2.58	1.41	0.23	1.41	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	54.04	8.15	3.92	4.23	1.21	1.21	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	44.16	4.65	4.07	4.36	0.87	0.29	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	50.89	7.19	3.20	1.87	0.27	0.80	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.08	1.31	0.88	2.63	0.88	1.31	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.33	3.64	0.91	2.73	2.28	2.73	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.82	2.24	1.49	2.24	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	31.33	3.96	0.72	3.24	0.36	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	27.91	3.74	2.30	2.88	0.86	0.29	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.04	5.19	1.89	1.41	1.18	0.24	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	43.73	6.34	1.58	2.22	0.00	0.95	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	37.52	4.61	3.08	3.69	0.62	1.54	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	38.15	1.60	3.21	2.89	0.32	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	36.72	6.50	2.29	1.91	0.38	1.15	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	48.08	5.12	1.18	4.34	1.18	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	3.03	3.03	2.27	0.76	0.76	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	47.37	4.82	7.23	4.01	4.82	1.61	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	41.27	3.50	7.69	6.99	2.10	0.00	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	42.07	4.01	8.01	3.01	1.00	1.00	4.01
Cardiac Myocyte, donor1	11525-119I4	5.48	7.31	0.00	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	26.68	3.95	1.98	1.48	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	13.26	3.79	1.37	1.05	0.63	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	13.17	5.89	1.04	1.39	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	12.44	2.49	1.07	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.88	3.19	1.93	0.80	0.68	0.11	0.23
Chondrocyte - re diff, donor2	11339-117F7	15.22	1.79	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	14.56	2.02	2.83	2.02	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	22.72	8.49	2.07	0.92	0.46	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	21.80	4.70	0.43	1.07	0.00	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	19.91	4.07	1.86	1.06	0.44	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.55	1.19	2.11	0.55	0.37	0.28	0.09
Corneal Epithelial Cells, donor1	11526-119I5	6.81	2.20	0.22	1.10	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	11.38	2.28	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.76	4.09	2.30	1.79	1.28	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	42.26	2.48	3.14	0.99	0.99	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	53.30	4.10	2.84	1.89	1.58	0.95	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	49.24	1.62	2.59	1.51	0.76	0.86	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.93	3.76	0.00	0.00	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	20.89	7.83	0.65	1.96	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.00	1.94	0.97	1.94	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	12.67	3.17	0.83	2.17	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	16.43	0.59	1.17	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.57	3.68	0.85	1.41	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	8.26	1.97	0.39	1.18	0.00	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	10.76	2.62	1.16	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	12.71	4.00	0.71	0.94	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	14.55	3.51	1.23	0.53	0.18	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.42	3.32	1.33	2.66	0.66	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.39	3.96	0.61	1.52	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.02	1.69	0.85	0.85	0.85	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	8.62	2.08	1.49	1.78	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	1.56	2.08	0.52	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	4.68	1.56	0.85	0.85	0.14	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	22.41	3.20	2.00	2.00	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	2.10	1.05	0.52	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.19	6.34	1.99	3.48	0.25	0.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	36.72	4.13	1.74	3.04	0.65	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.97	3.79	1.71	1.95	0.24	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	26.16	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.19	2.79	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	18.06	2.20	0.31	1.57	0.16	0.31	0.16
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	21.45	1.65	0.00	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	14.27	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.48	2.44	1.47	0.73	0.73	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.62	2.46	0.82	1.23	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.97	2.63	0.99	0.88	0.11	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.14	4.98	1.95	0.87	0.22	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.25	5.09	2.18	0.97	0.97	0.12	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.60	2.05	0.82	1.36	0.55	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.98	4.22	0.32	0.95	0.21	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	6.32	0.79	1.58	0.53	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.28	3.32	3.32	1.33	0.66	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	8.62	2.72	0.00	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	3.03	3.79	2.27	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.84	2.84	0.63	0.16	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	13.64	4.55	1.82	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	17.01	3.68	1.90	1.27	0.89	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	22.74	5.76	1.52	1.52	0.30	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.78	3.48	1.21	0.80	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.71	1.73	1.29	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	5.86	4.39	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.14	4.84	3.23	1.85	0.92	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	9.33	4.41	2.20	1.19	0.34	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	18.55	4.46	3.52	1.17	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	21.70	5.19	1.89	2.36	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.84	5.80	3.51	1.57	0.85	0.00	0.73
Fibroblast - Dermal, donor4	11450-119A1	29.17	5.65	3.05	1.24	0.23	0.34	0.11
Fibroblast - Dermal, donor5	11454-119A5	29.13	4.88	2.97	1.05	0.52	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	34.43	5.68	2.44	1.30	0.16	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	18.12	4.37	2.50	0.83	1.25	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.00	3.14	2.36	0.52	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	27.41	5.53	2.24	1.84	0.53	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	12.96	4.35	2.42	0.77	1.06	0.00	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	15.58	5.19	5.19	0.00	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.92	4.05	1.41	0.18	0.53	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.29	3.74	1.09	1.09	0.16	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.71	4.19	1.49	0.68	0.54	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.23	1.41	0.35	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.57	4.83	1.90	1.02	0.29	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.73	4.91	1.09	0.55	0.27	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	21.28	4.83	2.41	1.65	0.22	0.00	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.22	4.55	0.59	0.73	0.15	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	5.44	4.08	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	4.48	5.97	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	12.66	6.33	0.42	0.21	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	4.17	1.67	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	4.20	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.04	0.84	0.00	0.56	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.43	6.50	3.25	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	3.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	5.96	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.81	9.31	2.13	0.97	0.39	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	33.52	7.13	1.97	0.91	0.15	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.52	7.04	1.84	0.61	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	5.34	1.53	0.00	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.63	5.13	1.08	0.54	0.27	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.99	3.94	1.16	0.23	0.12	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	26.64	7.41	2.21	1.11	0.99	0.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.18	4.27	1.42	0.81	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	2.67	1.34	2.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.70	4.35	2.37	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	5.75	1.39	0.40	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.41	3.73	1.42	1.24	0.71	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.61	5.72	1.18	1.58	0.00	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	9.63	1.81	0.60	0.90	0.30	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.65	4.32	3.78	1.08	0.43	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.81	1.01	1.27	0.25	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	11.81	4.76	1.15	0.82	0.33	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	7.22	2.01	1.80	0.40	0.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	8.74	5.12	2.81	0.60	0.40	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	7.56	2.12	0.91	0.00	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.75	5.72	1.57	1.08	0.25	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	10.09	5.47	3.76	1.54	0.17	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	9.52	0.99	0.66	0.99	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	14.49	5.01	2.45	1.81	0.32	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	14.34	4.22	2.19	1.52	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.02	4.08	3.45	1.57	1.10	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	66.48	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	3.49	1.74	0.87	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	29.64	7.97	1.56	1.56	0.35	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	24.20	7.81	1.04	2.08	0.52	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	32.96	5.62	1.02	1.02	0.26	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	30.62	13.78	0.77	1.53	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	57.43	14.68	3.83	1.28	0.00	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	96.13	33.95	2.28	0.86	0.00	1.43	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.30	10.75	1.65	2.48	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.00	8.90	0.68	0.68	0.23	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	63.40	20.01	0.79	1.39	0.20	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	32.51	8.46	1.06	1.06	1.06	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.31	6.20	0.33	2.94	0.33	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	61.91	24.76	0.00	0.00	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	45.79	10.18	1.27	0.42	0.14	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.86	6.16	1.97	0.99	0.49	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	49.16	9.94	0.81	0.54	0.27	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	29.11	6.32	1.49	1.49	0.12	0.87	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.93	6.51	1.38	0.83	0.42	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.58	6.91	0.61	1.22	0.41	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.44	4.56	0.91	1.14	0.46	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	22.92	5.85	1.12	1.12	0.25	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.01	6.56	0.22	0.00	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.91	7.09	1.48	0.89	0.59	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.98	4.77	1.43	0.95	0.48	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.07	4.92	1.34	1.34	0.67	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.87	4.44	1.01	1.61	0.60	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.89	5.09	1.70	1.36	0.34	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.29	5.94	1.42	0.98	0.62	0.44	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.01	5.72	1.14	1.87	0.42	0.62	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.01	5.64	0.85	1.71	0.34	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	32.31	3.65	1.00	1.66	0.55	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.53	5.41	1.66	2.16	0.92	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.55	3.68	1.02	1.63	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.66	5.36	1.03	1.24	0.41	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.25	2.88	1.27	1.38	0.23	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.69	5.50	1.00	1.33	0.33	1.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.39	4.63	1.10	1.10	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	30.01	3.81	1.60	0.98	0.49	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.61	3.57	1.62	0.65	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.64	3.53	0.96	0.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.82	3.03	1.04	0.95	0.38	0.47	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.18	1.90	0.47	1.11	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	32.84	3.95	0.91	1.22	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	26.13	2.82	1.15	1.05	0.52	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	48.08	3.73	0.44	0.44	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.30	3.37	1.12	1.68	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.46	2.31	0.65	1.67	0.37	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	53.48	1.87	0.53	0.80	0.00	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	44.52	2.14	0.77	1.53	0.61	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.53	2.33	1.17	0.91	0.13	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	58.28	3.52	0.27	1.08	1.08	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.11	3.87	0.92	0.37	0.18	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.39	3.95	1.32	0.66	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	41.65	0.99	0.00	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.44	2.77	0.79	0.13	0.13	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.48	3.03	0.00	0.61	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	13.47	1.78	0.76	0.25	0.76	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	51.95	9.55	1.19	0.40	0.40	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	45.91	9.09	1.69	0.46	0.31	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	46.03	14.53	1.64	0.20	0.20	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	78.23	24.72	1.25	0.94	0.63	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	69.23	17.80	3.67	2.26	0.57	1.13	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	55.81	17.06	0.46	0.00	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	89.09	12.37	2.47	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	69.24	12.38	0.00	2.71	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	96.27	11.23	0.00	0.00	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	8.69	0.00	3.48	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	63.47	14.00	0.98	2.28	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	67.95	15.65	1.24	2.06	0.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	47.82	8.11	0.84	1.12	0.56	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	45.43	10.79	1.31	1.31	0.33	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	5.03	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	46.44	9.22	1.59	2.54	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	52.99	10.87	1.36	1.36	0.00	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	83.53	22.97	0.00	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	39.52	8.59	1.72	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.63	8.29	1.18	2.07	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	11.86	3.39	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	59.65	11.60	3.31	1.24	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	46.95	7.59	1.84	2.07	0.69	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.05	8.84	1.54	1.15	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	54.11	10.11	0.65	2.93	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	64.21	15.38	2.68	0.67	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	54.71	12.33	2.70	0.77	0.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	54.43	6.16	2.74	2.05	0.68	1.03	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	19.88	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	56.15	12.27	0.94	0.94	0.47	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	42.24	12.67	3.02	1.21	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	47.31	17.29	2.03	1.02	0.51	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	54.24	7.58	1.20	2.39	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	62.16	15.79	1.97	0.49	0.99	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	15.35	3.54	0.00	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	55.43	14.00	2.33	1.17	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.01	11.85	4.83	0.88	0.88	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	42.38	11.02	0.00	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.72	6.57	0.00	1.79	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.85	8.25	2.91	2.91	0.97	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	0.00	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	4.16	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	1.12	2.25	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.15	3.81	2.54	0.32	0.63	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.37	4.18	1.67	0.84	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	45.02	23.09	3.25	1.62	1.51	0.46	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	41.19	27.01	4.22	1.52	1.52	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	40.50	21.84	2.50	1.37	0.46	0.46	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.01	26.02	3.06	2.08	1.53	0.44	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.61	23.21	1.72	2.58	2.15	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	40.04	21.74	3.23	0.86	1.94	0.86	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	46.58	23.54	1.62	1.99	0.62	0.25	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	42.20	22.13	1.37	2.57	0.86	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	43.57	23.07	3.20	1.28	0.96	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	14.55	2.80	0.00	1.68	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	11.69	0.87	0.43	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	7.93	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.23	5.64	1.41	1.06	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	2.91	2.91	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	28.67	4.55	2.10	1.05	0.17	0.00	0.35
Hepatocyte, donor1	11523-119I2	19.37	0.00	2.42	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	20.47	4.31	2.15	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	17.18	1.84	0.61	1.23	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	37.86	9.14	5.22	7.18	0.65	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	33.38	11.01	2.10	0.52	0.70	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.80	6.72	0.96	1.37	0.82	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	15.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	6.68	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	12.46	0.00	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	5.01	5.01	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	10.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	48.73	3.25	8.12	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	1.67	3.33	1.67	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	10.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	10.59	2.65	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	12.20	3.33	1.11	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	5.24	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.82	10.08	4.41	0.00	1.26	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	35.57	9.28	1.55	3.09	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	11.63	2.58	2.58	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	4.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	28.52	8.96	4.07	0.81	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.15	5.46	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	8.04	4.82	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	22.16	1.85	1.85	0.92	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	31.63	6.14	4.25	2.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	25.40	6.35	1.81	0.91	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	4.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	3.81	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.68	5.10	1.28	3.19	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	3.65	0.00	0.00	5.47	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	18.57	4.28	1.43	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	3.32	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	26.24	4.94	5.56	0.93	3.09	0.31	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	8.78	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	15.72	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.30	2.09	2.09	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	6.48	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	4.36	1.74	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	4.50	6.75	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	13.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	7.47	5.33	0.00	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	9.70	2.77	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	8.55	2.85	0.00	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	9.20	2.76	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	12.42	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	4.23	1.06	1.06	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	7.67	3.59	0.98	0.33	0.24	0.16	0.08
Keratinocyte - epidermal, donor2	11349-117G8	6.44	0.59	2.34	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	24.99	7.19	3.03	0.57	0.38	0.00	0.09
Keratinocyte - oral, donor1	11251-116E9	17.03	10.10	4.65	1.36	1.02	0.00	0.57
Keratocytes, donor1	11527-119I6	35.76	6.53	3.09	1.38	1.38	0.34	0.00
Keratocytes, donor2	11607-120I5	24.61	4.69	2.34	1.17	4.69	1.17	0.00
Keratocytes, donor3	11688-122I5	38.73	7.11	2.96	0.59	2.96	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	4.40	6.59	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	3.24	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	18.91	4.73	1.15	0.46	0.35	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	11.40	3.94	1.72	1.41	1.01	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.49	2.73	1.42	1.30	0.36	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	2.23	1.12	1.95	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	14.64	2.05	2.20	2.05	1.26	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	14.52	2.69	2.15	2.69	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.61	3.47	3.15	1.58	0.32	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.54	1.83	0.86	1.94	0.75	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.77	0.82	1.23	2.87	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.40	2.28	2.02	1.77	0.51	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.43	2.11	1.41	1.83	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.45	3.56	2.37	1.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.54	3.30	1.16	1.16	1.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.26	2.22	0.74	2.04	0.37	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.24	3.83	1.74	2.09	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.73	1.91	1.91	2.62	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.34	1.65	0.96	1.92	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.01	2.77	1.85	2.16	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	2.81	1.56	1.56	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.52	2.74	0.91	1.65	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.84	2.63	2.63	1.65	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	2.34	0.29	1.17	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.96	2.24	0.50	1.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.03	3.39	2.42	3.39	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.70	2.96	1.62	1.35	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	12.56	3.63	1.67	1.67	0.45	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.41	1.04	2.59	1.56	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.08	3.14	1.26	1.47	0.63	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.32	3.16	1.05	1.35	0.45	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.88	4.82	1.38	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.24	1.51	0.75	1.32	0.56	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.22	1.59	0.85	1.17	0.21	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	3.39	1.94	3.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.56	3.31	0.99	0.99	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.55	1.36	0.99	2.11	0.37	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	2.96	1.11	1.11	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.34	2.22	1.98	0.74	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.94	1.51	0.55	1.51	0.41	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.40	3.86	1.29	1.61	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.17	2.74	0.61	3.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.62	2.94	1.40	2.66	0.28	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.42	3.20	1.07	1.42	1.42	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.03	3.39	0.97	0.97	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.34	1.40	0.47	1.09	0.16	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	19.34	5.37	1.07	2.51	1.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	3.59	1.31	0.98	0.65	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	1.88	1.41	0.94	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.62	2.48	2.23	2.35	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.55	1.28	0.51	1.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.85	3.28	1.49	2.98	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	6.80	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	4.60	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.16	5.94	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.65	3.39	0.42	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	2.81	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	3.74	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	2.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	4.76	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.65	4.98	0.00	0.00	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.21	6.11	0.00	0.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	11.25	8.10	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	6.23	5.96	0.27	0.27	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	4.11	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.00	6.35	0.71	0.71	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	10.66	6.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	10.19	5.09	0.51	0.00	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	6.40	0.80	1.07	0.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.34	6.80	0.00	0.76	0.38	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.98	4.91	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	9.79	7.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.08	8.12	0.42	0.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.05	4.48	0.56	0.28	0.56	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	5.15	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.77	6.97	0.29	0.58	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.97	4.48	0.60	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.96	3.87	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.78	3.18	0.35	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	6.64	4.43	0.37	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	4.61	3.45	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.75	3.84	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.23	1.13	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	4.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.68	5.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	4.31	0.00	2.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	13.44	4.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.78	5.95	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	4.74	0.43	0.86	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	7.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.66	5.33	0.33	0.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	4.22	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	2.13	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.25	5.84	0.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	1.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	5.39	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.04	3.70	0.74	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	9.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	2.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.60	2.80	0.40	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	3.63	2.18	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	4.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.37	4.44	0.00	0.00	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	4.70	2.82	1.88	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	5.53	0.00	0.50	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.01	4.96	0.00	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	3.44	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	4.90	2.23	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.04	5.08	1.17	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	7.26	1.32	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.86	4.15	0.52	2.08	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.75	3.50	0.00	0.44	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	6.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.83	4.86	0.44	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.64	4.24	0.00	0.39	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	4.56	4.56	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.09	5.29	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	8.35	6.36	1.59	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.11	6.08	0.00	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	6.92	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.12	6.46	1.14	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	6.20	2.07	0.00	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	2.42	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	9.51	5.07	0.00	0.32	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.60	2.13	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	2.87	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	4.63	0.00	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	5.66	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.08	3.97	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	4.58	3.74	0.00	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.92	1.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.86	4.59	0.84	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	1.86	0.46	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	5.35	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.23	4.28	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.27	5.25	0.40	0.00	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	3.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.00	2.67	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	5.13	0.57	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	7.67	3.83	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.77	3.28	0.55	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.80	5.79	0.45	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.06	5.98	0.26	0.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	3.98	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	50.60	2.51	2.51	0.91	0.68	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	41.47	3.12	1.65	0.37	0.55	0.73	0.55
Macrophage - monocyte derived, donor3	11389-118C3	23.33	1.70	2.23	0.79	0.26	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	51.51	13.28	2.66	5.31	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	13.31	4.60	2.38	1.43	0.79	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	31.27	8.20	2.08	1.53	0.69	0.00	0.28
Mammary Epithelial Cell, donor1	11273-116H4	21.62	9.37	4.38	0.90	1.99	0.00	0.30
Mammary Epithelial Cell, donor2	11350-117G9	18.82	6.95	4.34	2.03	1.16	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	7.98	6.98	0.25	0.75	0.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	6.10	1.36	0.68	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	16.55	2.92	2.70	1.08	0.87	0.11	0.11
Mast cell, donor2	11565-120D8	5.94	1.49	0.89	0.30	0.30	0.30	0.30
Mast cell, donor3	11566-120D9	4.50	0.23	1.58	0.90	0.68	0.00	0.00
Mast cell, donor4	11567-120E1	7.27	0.71	0.35	0.53	0.35	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	44.47	3.99	4.10	3.44	1.22	0.33	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	27.43	1.75	1.17	0.58	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	28.91	3.44	2.98	1.72	1.03	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	31.30	2.01	2.51	2.68	0.50	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	19.00	2.69	2.59	4.08	0.99	0.00	0.30
Melanocyte - dark, donor2	11582-120F7	24.92	4.85	1.38	1.04	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	41.87	2.10	2.17	0.72	0.80	0.14	0.00
Melanocyte - light, donor1	11274-116H5	16.46	0.71	0.24	0.00	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	16.38	0.68	0.00	0.68	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	6.94	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	51.96	3.75	0.42	0.73	0.21	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	31.47	5.11	1.34	0.27	1.08	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	52.50	2.95	0.80	1.07	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	23.32	5.33	1.24	0.62	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	40.49	4.40	2.20	1.32	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	27.87	5.38	1.14	1.63	0.16	0.49	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	37.93	10.55	2.57	1.71	0.57	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.16	4.03	1.71	0.70	0.30	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	54.54	8.61	1.44	2.87	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.92	2.75	0.42	0.64	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.58	2.01	0.00	0.00	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.92	7.03	2.42	1.98	0.88	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.84	5.11	2.92	2.19	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	14.94	4.71	2.86	2.66	0.41	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.44	4.99	3.74	0.97	0.42	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.23	2.97	1.86	0.74	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.21	5.00	2.37	1.32	0.53	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	2.08	1.19	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00	0.00	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.93	4.48	3.20	0.64	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.53	14.18	1.42	3.19	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.70	3.75	2.50	0.63	0.63	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	55.15	5.81	4.35	3.63	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	21.48	7.16	0.80	1.59	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	25.02	8.01	0.00	3.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	13.80	5.35	0.79	0.51	0.29	0.07	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	56.71	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	52.95	2.22	1.97	0.74	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.10	3.53	1.18	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	41.84	2.48	0.93	0.62	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.70	3.11	1.04	0.41	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	41.69	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.30	3.00	2.75	0.75	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	29.33	0.93	0.93	0.93	0.00	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	42.27	3.45	1.22	1.02	0.81	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.93	2.77	0.79	1.58	0.00	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	1.77	0.00	2.65	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.79	0.76	1.52	1.14	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	32.68	1.27	0.85	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.94	0.92	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.72	4.47	0.60	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	1.68	0.00	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	31.11	2.01	2.26	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.33	2.85	1.19	1.19	0.24	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	30.96	1.11	0.00	1.11	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.46	2.53	0.46	1.15	0.46	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.56	2.10	1.26	0.00	0.42	0.84	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.31	1.63	0.00	0.61	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	31.75	2.79	0.43	0.43	0.21	1.07	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.90	1.11	1.33	1.11	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.84	2.41	0.22	0.44	0.22	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.33	2.03	0.51	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.02	2.72	0.54	0.54	0.54	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.06	1.18	0.88	0.29	0.00	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	20.72	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	21.14	4.81	0.00	0.96	0.00	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.82	1.60	0.00	0.80	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	28.03	4.51	0.00	0.50	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	25.84	2.19	1.31	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.74	1.28	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.26	3.97	0.25	0.50	0.50	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	25.05	0.70	0.70	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	31.11	3.42	0.34	1.03	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.07	3.06	0.88	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.76	2.13	0.00	0.00	0.00	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.14	4.21	0.84	0.84	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	38.65	3.33	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	29.72	0.58	0.00	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.51	3.02	0.00	1.21	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.31	4.17	1.67	0.83	0.00	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	2.77	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	45.53	6.26	0.57	0.00	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.92	2.35	1.11	0.69	0.00	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.91	4.41	0.52	1.04	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	52.76	4.72	0.86	0.86	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	31.76	1.27	0.64	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	30.43	5.87	0.27	0.53	0.00	1.07	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	47.59	7.18	1.50	2.10	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	28.96	1.41	0.42	0.14	0.14	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.36	3.50	1.59	1.27	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	53.51	5.53	2.43	0.66	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	32.61	5.31	0.00	1.90	0.00	1.52	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	40.06	4.26	0.28	2.27	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	56.04	5.90	2.46	1.72	0.00	1.47	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	39.10	0.65	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	31.46	6.17	1.76	1.47	0.59	0.00	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	60.55	5.19	1.15	3.17	1.15	1.44	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.61	1.65	0.41	0.00	0.41	1.65	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	31.27	3.28	1.49	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	56.50	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	5.35	3.56	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	39.76	1.31	1.31	1.97	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	49.44	4.21	0.00	3.16	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	39.54	3.36	1.19	0.99	0.20	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	42.84	3.73	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	36.43	3.38	2.63	1.50	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	59.13	1.60	1.60	0.53	0.27	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	39.36	3.73	1.70	0.90	0.34	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.89	1.47	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	41.04	2.93	0.73	0.00	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	0.00	0.00	4.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	48.63	4.81	2.14	1.07	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	7.73	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	18.18	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	43.85	1.69	0.84	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	31.32	0.00	0.00	4.09	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	21.62	4.45	1.27	1.91	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	38.87	4.86	2.43	0.81	0.81	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	42.29	1.51	0.00	4.53	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	39.15	6.52	3.26	3.26	0.00	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.93	4.09	1.08	0.86	0.22	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	15.16	5.23	1.05	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	23.36	2.00	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.94	0.83	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.62	8.75	1.14	0.57	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	6.38	0.00	4.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	1.36	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	29.40	16.54	3.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.16	2.09	0.42	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.01	2.32	0.46	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.48	3.24	0.27	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.44	3.99	0.84	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.92	0.99	0.99	1.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.05	4.33	0.00	0.54	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.68	4.08	0.23	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.58	2.29	0.16	0.49	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.97	4.01	0.91	0.73	0.00	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	2.12	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	1.20	0.60	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	26.91	2.95	1.31	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.10	1.63	0.65	0.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.64	5.29	1.06	1.94	0.18	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	2.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.33	2.76	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	27.31	3.53	0.32	0.64	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.49	6.55	1.72	0.69	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	53.10	32.87	5.06	5.06	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.84	5.12	0.89	1.11	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	7.20	3.39	0.85	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.92	4.98	0.47	0.24	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	28.76	2.58	0.00	0.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.99	3.67	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.09	3.16	0.90	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.11	1.98	0.40	1.19	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	0.93	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.62	2.65	0.00	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.36	1.96	0.33	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.69	1.74	0.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	22.61	2.26	1.81	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	2.66	2.66	1.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.77	2.48	0.00	0.99	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.19	1.53	1.15	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.05	4.54	2.42	1.51	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.90	3.98	0.88	0.88	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	2.71	0.00	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	40.88	5.11	10.22	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.87	3.66	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.48	1.57	0.31	0.63	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.83	0.61	0.61	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	1.58	0.79	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	5.67	1.13	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	20.23	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	19.63	7.33	1.37	1.99	0.50	0.12	0.25
Myoblast, donor2	11322-117D8	24.36	6.33	2.11	2.11	1.15	0.38	0.00
Myoblast, donor3	11398-118D3	17.15	4.71	1.01	1.51	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	45.68	4.52	4.23	4.67	3.06	0.73	2.19
Natural Killer Cells, donor1	11230-116C6	8.30	2.15	0.92	0.92	0.31	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	8.14	1.51	0.90	1.21	0.90	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	6.99	0.74	0.18	0.55	0.74	0.55	0.00
Neural stem cells, donor1	11275-116H6	9.07	1.81	0.73	1.81	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	9.63	7.70	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	33.00	7.97	1.14	3.41	1.14	0.00	1.14
Neurons, donor2	11574-120E8	18.05	4.62	0.88	0.22	0.44	0.00	0.22
Neurons, donor3	11655-122E8	25.49	4.93	6.58	0.82	2.47	0.00	1.64
Neutrophils, donor1	11233-116C9	6.50	0.00	0.00	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	7.33	0.00	0.61	1.22	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	11.28	5.22	2.97	0.59	0.59	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	11.40	4.23	0.65	0.98	0.65	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	10.83	5.21	2.01	1.20	0.40	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	10.19	4.27	1.51	0.96	0.41	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	12.01	4.78	2.32	0.87	0.29	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	9.87	2.84	1.70	0.34	0.11	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	9.93	3.31	1.66	0.49	0.19	0.00	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	16.85	6.62	0.60	1.20	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	5.96	4.89	1.49	1.06	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	13.72	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	22.35	4.97	1.24	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	13.29	4.30	1.37	0.78	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	14.05	7.02	2.11	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	14.04	3.55	1.42	1.78	0.36	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	16.26	5.56	1.85	1.77	0.76	0.08	0.00
Pericytes, donor1	11491-119E6	4.78	1.89	2.23	0.89	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	12.45	1.36	0.91	1.13	0.91	0.00	0.00
Pericytes, donor3	11652-122E5	9.16	2.44	0.81	1.02	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	17.74	4.29	1.70	1.47	0.23	0.00	0.00
Perineurial Cells, donor2	11579-120F4	21.90	4.97	1.84	1.38	0.37	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	14.34	1.91	2.55	1.91	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.41	2.45	0.24	0.00	0.49	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5.82	1.29	0.91	0.39	0.39	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	4.78	5.98	0.48	0.48	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	4.44	2.22	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.93	0.98	0.79	1.18	0.20	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.59	1.58	0.32	0.32	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	9.75	2.81	1.13	1.13	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.05	1.17	0.65	0.91	0.39	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	13.51	2.70	1.13	1.35	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	12.68	1.70	0.75	0.85	0.43	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	10.04	3.49	0.87	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	11.89	2.15	0.86	1.00	0.29	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.53	0.92	0.61	1.23	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	34.88	8.50	2.48	1.06	0.35	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	25.54	6.64	1.53	0.85	0.51	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	23.47	8.29	3.17	1.86	0.84	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	18.41	5.06	1.84	0.92	0.46	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	28.00	5.85	1.78	1.57	0.10	0.21	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.53	11.92	1.51	0.60	1.06	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	12.05	3.11	1.22	1.08	0.68	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	16.47	7.78	0.73	1.04	0.49	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	25.86	8.66	2.28	1.59	0.80	0.34	0.34
Prostate Stromal Cells, donor2	11332-117E9	40.70	6.45	1.61	1.79	0.90	0.72	0.54
Prostate Stromal Cells, donor3	11405-118E1	21.38	5.74	1.67	1.77	0.63	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	2.19	1.46	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.39	4.71	1.18	0.28	0.28	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	4.57	3.55	0.51	1.52	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.94	2.13	0.00	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	14.72	4.45	1.59	0.64	0.42	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	0.68	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.04	2.83	1.48	2.70	0.27	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	28.20	6.66	1.33	0.89	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	1.33	0.00	0.00	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	15.19	2.42	1.32	1.10	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	22.57	3.13	0.63	1.88	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.21	2.77	0.55	0.55	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.38	5.10	2.15	1.88	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.92	3.80	1.27	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.43	3.28	0.77	0.39	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.85	9.33	0.78	0.26	0.78	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	23.31	4.83	0.57	1.14	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	17.50	3.09	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.53	5.27	0.75	0.25	0.75	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	18.31	2.94	2.54	1.20	0.80	0.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	1.79	0.89	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.60	2.75	0.55	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	6.38	2.90	0.00	0.58	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.41	3.64	0.52	0.52	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.94	2.58	0.30	0.40	0.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.47	4.35	0.33	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.40	3.60	0.62	0.25	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.74	3.15	0.82	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	8.78	3.24	0.00	0.69	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.27	2.05	0.14	0.27	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.41	4.24	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	7.35	3.76	0.72	0.54	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	9.04	1.58	0.14	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.05	2.79	0.21	0.32	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.41	2.88	1.11	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	6.12	0.96	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.71	3.63	0.19	0.19	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	5.83	2.63	0.75	0.00	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.75	1.59	0.40	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.13	3.21	0.10	0.10	0.29	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	7.45	3.44	0.57	0.57	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.30	2.67	0.32	0.11	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	5.61	2.80	0.28	0.56	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.18	3.59	0.00	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.11	2.19	0.18	0.00	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4.66	1.96	0.25	0.37	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	7.92	3.22	0.00	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.73	2.12	0.00	0.71	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.95	3.37	0.60	0.79	0.00	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	6.08	3.74	0.47	0.00	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.50	3.11	0.41	0.21	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	3.98	1.99	0.22	0.00	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	5.85	1.46	0.21	0.00	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	8.61	3.63	0.40	0.27	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	8.00	2.38	0.34	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	10.03	1.93	0.19	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	9.97	2.06	0.17	0.34	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.68	2.06	0.41	0.27	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.19	2.96	0.33	0.66	0.16	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.69	0.85	0.34	0.34	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.99	2.52	0.59	0.15	0.15	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.33	2.93	0.53	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.19	1.38	0.55	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.24	1.43	0.48	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	9.67	2.62	0.20	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.12	1.60	0.00	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	5.94	2.79	0.35	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	7.56	2.72	0.30	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.10	1.22	0.37	0.24	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	8.44	4.22	0.44	0.44	0.44	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.99	3.04	1.83	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	8.44	1.21	0.00	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	7.69	0.90	0.00	0.23	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	5.39	2.10	1.20	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	6.38	2.24	0.47	0.47	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	7.04	1.28	0.21	0.64	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.21	1.80	0.60	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	12.98	1.13	1.50	1.13	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	23.82	3.40	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	38.78	4.82	1.10	0.66	0.00	0.44	0.00
Sebocyte, donor1	11220-116B5	14.24	5.48	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	13.79	2.76	1.38	0.46	0.92	0.00	0.92
Sebocyte, donor3	11378-118B1	8.24	2.47	1.03	0.62	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	9.94	1.66	1.66	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	8.47	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	9.77	4.75	1.23	1.06	0.62	0.00	0.26
Skeletal Muscle Cells, donor2	11358-117H8	4.34	2.89	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	4.18	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	34.25	8.95	3.61	3.46	0.79	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	32.11	6.54	3.72	2.08	0.59	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	42.17	8.93	3.69	2.15	0.62	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	19.40	6.05	4.28	1.89	1.39	0.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.54	4.42	2.28	2.14	0.57	0.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	56.35	7.94	1.98	2.98	0.50	0.40	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.60	6.15	0.67	1.10	0.51	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	6.51	1.45	1.45	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.20	3.72	0.69	0.69	0.14	0.28	0.00
Skin - palm, donor1	10286-104F7	13.43	2.69	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.69	4.47	0.72	1.01	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	1.64	1.64	0.82	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.58	2.08	1.43	0.52	0.52	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	21.41	9.73	3.20	3.06	1.67	0.42	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	19.27	5.77	1.97	1.83	0.98	0.56	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	16.07	3.38	2.33	3.17	1.27	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	20.54	6.30	1.20	2.40	0.45	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.90	2.16	0.62	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.45	0.89	0.44	0.67	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	3.53	0.59	1.76	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.30	2.43	1.10	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	2.76	0.00	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	4.64	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	41.03	8.01	2.00	2.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.45	3.86	0.80	0.67	0.27	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.41	2.22	2.66	1.11	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.78	4.35	1.66	1.66	0.00	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.77	8.47	1.95	3.58	0.33	0.33	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.08	6.20	1.48	1.18	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.93	5.55	0.57	1.00	0.14	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.04	3.58	1.30	1.14	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.18	7.31	0.91	0.91	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.30	1.26	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	2.86	0.48	1.91	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	27.73	7.96	1.77	0.74	0.59	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	37.45	5.17	0.86	1.08	0.22	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	36.21	5.88	0.84	0.94	0.21	0.21	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.51	2.17	0.46	1.24	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	3.23	2.16	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	1.49	0.60	0.90	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.46	5.46	0.68	1.02	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	28.74	6.91	1.41	1.41	0.31	0.08	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.94	2.42	1.11	0.40	0.50	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.43	5.23	2.05	1.82	1.37	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	1.21	0.00	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	58.02	15.37	1.85	1.85	0.53	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.04	5.99	1.73	1.33	0.00	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.67	6.26	1.88	1.38	0.88	0.88	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.64	2.79	1.27	0.00	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.12	2.26	0.75	0.90	0.30	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	6.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	3.26	0.93	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.56	3.03	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.01	2.19	0.63	1.57	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.57	2.65	2.06	0.59	1.47	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	41.90	10.16	3.00	2.00	1.08	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	1.40	0.47	1.40	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.06	2.73	1.15	0.43	0.29	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.87	4.59	0.76	1.53	0.25	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.41	2.07	0.94	0.19	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	28.93	6.99	2.24	0.84	0.28	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.42	6.62	1.76	0.92	0.59	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.33	0.48	0.00	0.48	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.63	0.98	0.73	1.96	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.77	5.08	2.21	1.55	0.22	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.23	7.02	2.05	0.59	0.29	0.29	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.63	4.86	1.17	0.58	0.58	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.51	3.70	1.32	0.00	0.53	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	5.21	5.58	1.86	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.81	7.91	1.80	0.36	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.98	5.68	1.14	1.70	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.57	11.42	1.18	1.18	0.39	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	13.71	5.59	4.06	0.76	0.76	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	10.38	3.59	0.80	0.80	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	20.48	6.69	1.67	0.84	0.84	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	20.63	7.79	1.38	1.38	0.92	0.00	0.46
Synoviocyte, donor1	11291-117A4	7.41	2.36	0.67	0.00	0.50	0.00	0.00
Synoviocyte, donor2	11368-117I9	12.91	3.02	1.17	0.17	0.34	0.17	0.00
Synoviocyte, donor3	11440-118H9	10.50	3.13	1.56	0.67	0.45	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	41.81	7.15	5.36	2.86	1.07	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	47.57	7.93	0.00	5.95	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.27	1.62	0.46	0.69	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.20	5.66	2.65	1.29	1.51	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	1.93	1.16	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	0.00	2.29	0.57	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.31	2.83	2.21	1.35	1.11	0.00	0.25
Urethra, donor2	10319-105A4	12.59	1.80	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.42	3.98	1.59	1.86	1.06	0.00	0.27
Urothelial Cells, donor2	11600-120H7	7.61	2.00	2.00	1.20	0.80	0.00	0.40
Urothelial Cells, donor3	11681-122H7	6.42	1.15	1.38	0.92	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	13.60	5.13	2.23	1.78	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	12.46	2.67	3.56	1.78	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	1.43	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.90	2.05	2.74	0.00	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.08	3.10	2.75	2.07	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.94	5.23	2.32	1.16	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	12.49	1.04	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	13.77	2.75	2.75	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	12.78	1.83	1.83	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	22.82	6.66	2.71	2.10	0.86	0.00	0.37
Wilms' tumor cell line:HFWT	10597-108E3	15.84	6.16	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	53.63	13.13	5.31	0.84	1.68	0.28	0.28
achilles tendon, donor2	10292-104G4	6.20	0.00	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	72.41	4.08	7.39	7.14	1.78	1.53	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	41.33	6.04	4.88	10.22	1.63	1.63	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	31.81	3.92	1.42	3.21	0.95	0.59	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	71.29	13.61	2.72	5.71	0.54	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	55.65	4.78	2.53	4.50	2.25	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.26	6.13	3.17	3.17	3.17	0.00	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	31.85	5.17	6.53	4.63	4.36	0.00	2.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	36.57	3.53	3.08	0.88	2.20	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	19.60	3.27	5.72	11.84	1.23	0.41	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	29.51	4.66	2.33	6.21	2.33	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	68.63	9.38	2.39	2.21	1.29	0.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	3.90	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.74	3.02	2.09	1.39	0.70	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	67.57	6.21	0.52	1.81	0.00	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.25	9.06	2.05	1.17	0.00	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	25.56	1.39	1.86	2.32	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	36.19	6.58	2.06	0.82	0.41	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	41.13	6.45	0.92	3.99	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	46.94	11.52	5.55	3.41	1.28	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	44.58	9.40	3.64	4.55	1.21	1.21	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	47.18	10.35	3.37	4.81	1.93	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	100.90	4.68	5.35	4.23	1.56	1.56	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	48.03	4.67	1.67	2.67	0.67	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	3.72	3.72	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	20.72	4.90	4.14	4.52	1.51	1.13	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.75	2.18	5.67	3.05	1.74	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	5.62	5.62	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	48.28	6.12	4.24	0.94	2.12	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	7.91	1.86	1.86	0.47	0.93	0.00	0.00
adipose, donor1	10184-103D4	47.50	22.87	4.69	2.93	1.17	0.59	0.00
adipose, donor2	10185-103D5	16.22	7.30	0.00	0.00	0.00	1.22	0.41
adipose, donor3	10186-103D6	29.41	8.17	0.27	1.36	0.27	0.00	0.27
adipose, donor4	10187-103D7	39.00	19.94	3.47	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.52	18.31	1.74	3.63	0.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.61	3.87	8.27	0.80	2.67	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.80	6.07	1.79	2.14	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	9.74	2.32	0.93	0.70	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	13.52	6.09	4.06	0.68	1.35	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	6.78	2.65	1.77	0.88	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	41.50	1.19	3.56	1.19	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	25.75	2.43	2.23	2.03	1.22	0.00	0.81
amygdala, newborn, donor10223	10360-105E9	25.50	2.58	0.65	1.29	0.32	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	11.97	6.11	1.53	0.89	0.51	0.00	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	81.63	6.18	4.63	1.99	0.66	1.76	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	22.05	5.01	1.67	0.33	0.00	0.67	0.00
aorta, adult, pool1	10052-101G7	5.88	0.78	1.37	0.39	0.00	0.00	0.00
appendix, adult	10189-103D9	21.35	1.94	1.16	3.10	1.16	0.00	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.30	8.25	2.75	1.38	0.69	0.34	0.00
artery, adult	10190-103E1	29.89	5.43	5.43	0.00	2.72	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	30.57	6.66	3.19	1.59	2.03	0.14	0.72
b cell line:RPMI1788	10427-106D4	21.56	5.50	6.84	1.78	2.53	0.15	1.64
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.16	3.05	2.22	1.94	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	15.78	11.41	1.69	0.89	0.89	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	192.15	61.09	7.70	6.70	3.68	5.86	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.11	3.91	5.59	1.12	2.24	0.56	0.56
bladder, adult, pool1	10011-101C2	11.41	1.30	1.41	0.87	0.33	0.00	0.00
blood, adult, pool1	10053-101G8	8.86	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	4.28	4.28	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	18.90	2.02	1.35	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	16.40	3.08	4.10	2.05	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	17.59	1.89	2.67	0.67	1.22	0.11	0.56
brain, fetal, pool1	10085-102B4	21.37	5.34	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.86	12.88	0.00	0.99	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.71	11.73	4.62	2.37	1.25	0.25	0.87
breast, adult, donor1	10080-102A8	17.05	0.63	1.26	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.87	18.93	4.32	1.52	0.64	0.13	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.17	12.06	1.24	0.00	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.74	26.01	4.60	2.30	0.92	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	24.93	13.07	4.84	0.73	1.45	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	33.38	12.69	4.70	1.88	2.35	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	23.08	8.64	1.86	0.98	0.66	0.00	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	18.06	9.19	0.32	0.00	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.55	14.91	2.40	0.80	0.27	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	27.63	1.15	1.15	4.61	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	22.92	1.17	1.17	0.84	1.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	16.05	3.82	3.82	1.53	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	32.23	2.93	1.10	1.10	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	26.22	2.91	5.83	0.00	0.00	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	24.98	2.56	1.07	1.92	2.14	0.00	0.21
cerebellum, adult, pool1	10083-102B2	13.45	1.03	1.72	0.34	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	41.51	4.15	2.49	2.49	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	20.42	2.27	3.28	1.51	0.76	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	18.27	2.19	0.73	2.92	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	22.72	42.85	7.76	1.29	3.74	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	12.93	7.95	2.32	0.50	0.66	0.17	0.50
cervix, adult, pool1	10013-101C4	9.66	2.20	1.68	0.73	0.42	0.00	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.67	6.97	1.39	1.67	0.56	0.14	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	33.96	7.84	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	39.64	15.78	3.73	1.24	0.62	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	18.97	10.10	1.85	0.25	0.74	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	43.64	14.47	1.66	1.42	0.71	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	9.97	1.99	1.99	0.57	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	17.40	5.07	0.99	0.50	0.30	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	8.79	3.30	3.85	0.55	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	45.44	8.08	1.01	6.06	0.00	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	39.19	7.11	3.27	2.50	0.77	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	17.74	3.17	4.65	5.28	2.75	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	60.09	21.06	3.34	3.08	1.28	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	65.07	24.67	5.32	3.63	2.66	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	63.73	18.94	4.89	3.26	0.61	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	110.72	31.21	4.12	4.12	1.18	0.88	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	26.32	5.21	4.17	3.39	1.56	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.26	6.86	3.89	2.29	0.91	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	12.15	7.98	3.99	0.52	0.69	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	30.57	26.91	1.46	0.92	0.00	0.37	0.55
colon carcinoma cell line:COLO-320	10420-106C6	25.09	7.22	1.14	0.00	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	10.71	3.57	0.00	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	20.92	4.11	2.12	0.82	0.59	0.00	0.12
colon, fetal, donor1	10070-101I7	17.92	2.47	2.47	0.62	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	48.87	12.75	4.25	5.95	1.70	2.12	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	56.15	7.40	4.83	8.15	1.51	2.41	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	58.80	10.15	6.77	6.35	3.10	1.69	2.40
corpus callosum, adult, pool1	10042-101F6	9.62	0.66	1.88	0.33	0.66	0.00	0.22
cruciate ligament, donor2	10295-104G7	14.59	3.24	3.24	2.43	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.89	1.61	4.01	2.41	1.61	0.00	0.00
diencephalon, adult	10193-103E4	16.08	3.36	1.20	0.72	0.72	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	69.11	5.74	3.44	2.98	1.61	0.69	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.54	12.31	4.10	1.80	1.54	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	44.53	6.50	2.65	1.69	2.89	1.20	1.44
ductus deferens, adult	10196-103E7	18.44	1.99	0.00	1.50	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	2.88	1.44	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	31.63	3.68	0.74	1.47	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	5.04	0.91	0.74	0.50	0.50	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	62.40	30.20	9.99	7.77	8.22	4.22	4.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	69.07	41.84	2.87	2.01	0.72	1.15	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	39.46	12.95	2.47	2.47	1.23	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	22.40	13.02	0.91	2.42	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	54.34	13.58	2.78	3.40	0.62	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	52.54	15.76	7.88	3.94	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	25.81	19.78	10.73	1.34	2.35	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.37	11.60	4.17	3.08	0.91	0.00	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.24	8.84	0.80	0.16	0.32	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	29.12	6.78	6.34	1.22	2.11	0.11	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	28.38	12.65	1.21	1.54	0.44	0.22	0.22
epididymis, adult	10197-103E8	11.09	2.51	1.47	0.84	1.05	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	13.66	6.39	2.84	3.19	0.89	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.02	5.51	0.39	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	70.24	20.84	4.72	2.75	3.54	1.31	1.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	52.56	18.60	6.40	2.56	3.15	1.08	1.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	68.79	17.25	4.03	3.36	3.02	0.78	1.34
esophagus, adult, pool1	10015-101C6	14.55	3.72	1.49	0.53	0.74	0.00	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.80	10.39	2.13	1.75	0.25	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	7.24	2.41	2.41	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	22.32	1.49	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	9.17	1.15	1.15	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	0.00	1.46	0.00	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	12.20	2.03	3.56	1.27	0.76	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	35.01	3.21	2.56	1.54	1.15	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.81	5.46	2.37	3.09	0.24	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	24.11	2.91	1.78	1.13	1.03	0.00	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	25.82	30.33	6.31	1.20	2.10	0.00	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.20	9.42	2.74	1.46	0.82	0.55	0.09
gall bladder, adult	10198-103E9	15.69	3.14	1.93	1.21	0.48	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	25.77	2.68	6.44	4.29	1.07	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	7.84	3.36	3.36	1.12	0.00	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.70	3.59	3.38	1.69	1.27	0.00	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	25.34	10.25	0.77	0.58	0.39	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	28.69	17.05	1.48	2.62	0.66	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	19.22	10.07	0.92	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.59	4.80	1.83	1.37	0.91	0.91	0.69
giant cell carcinoma cell line:LU65	10487-107B1	32.13	26.62	2.41	1.84	0.34	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	14.28	7.42	3.08	0.70	1.26	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.44	14.97	2.49	2.24	2.24	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.26	8.23	1.69	1.27	0.32	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.64	9.69	2.53	0.70	0.42	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	43.38	7.95	7.17	4.75	2.87	3.20	1.10
glioma cell line:GI-1	10413-106B8	33.68	19.62	1.17	1.76	0.88	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	28.43	0.73	2.19	1.46	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	19.77	1.46	2.93	1.22	0.49	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	16.43	1.37	2.74	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.19	1.07	2.13	2.66	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	12.24	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	10.93	0.00	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	10.45	5.23	5.23	10.45	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.96	1.28	0.64	0.32	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	52.34	6.89	2.30	0.46	1.38	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	43.44	11.89	4.57	1.37	0.46	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	50.24	11.59	1.93	0.00	0.64	1.29	0.64
hIPS, biol_rep1	14380-156B6	73.30	4.31	0.00	1.44	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	51.44	6.86	2.06	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	24.28	2.21	4.41	0.00	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	30.75	2.87	6.32	6.03	1.72	0.57	0.29
heart - mitral valve, adult	10205-103F7	12.56	0.60	3.59	1.49	1.20	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	12.29	1.31	5.49	0.26	1.05	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	13.32	0.83	0.83	2.50	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	16.32	7.35	1.63	0.82	0.41	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	17.03	0.85	0.85	0.43	0.85	0.00	0.85
heart, adult, pool1	10016-101C7	22.54	3.22	1.38	1.84	0.69	0.00	0.00
heart, fetal, pool1	10046-101G1	21.87	3.29	2.98	1.75	1.44	0.31	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.49	2.78	2.16	0.93	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	82.05	16.65	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	78.45	12.60	5.30	3.54	5.97	2.98	2.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	87.27	13.23	5.10	3.40	4.85	3.03	2.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	71.65	13.04	5.76	3.94	4.65	2.83	4.04
hepatoma cell line:Li-7	10484-107A7	95.20	19.02	2.11	1.89	1.78	3.11	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	50.65	9.35	3.02	1.11	1.11	1.11	0.30
hippocampus - adult, donor10196	10169-103B7	36.91	3.79	1.89	1.89	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	22.04	2.86	3.27	1.02	1.63	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	29.38	3.49	2.49	1.99	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	21.15	3.52	2.11	1.41	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	107.42	43.33	0.61	4.27	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	61.07	21.60	0.79	0.59	0.20	0.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	64.49	24.88	0.51	0.25	0.25	1.52	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	27.63	5.64	1.13	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.34	9.81	1.81	1.03	0.77	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.99	15.56	0.38	1.52	0.38	0.38	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	27.44	6.42	0.88	0.00	0.00	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	25.42	6.46	0.00	0.22	0.22	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	27.53	6.67	1.25	2.09	0.00	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	39.31	7.81	1.89	1.42	0.71	0.47	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.39	6.59	1.29	2.09	0.16	0.64	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	49.15	14.14	2.69	2.02	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	41.16	18.47	0.78	0.00	0.31	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	51.09	16.21	0.49	0.98	0.49	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	56.73	34.04	2.62	0.00	1.75	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	21.95	7.25	0.95	1.53	0.38	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	23.11	8.72	1.74	2.18	1.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	26.99	11.99	1.50	1.00	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.01	5.65	0.57	0.75	0.19	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.01	4.09	0.91	0.00	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.35	3.76	0.31	0.63	0.94	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.56	4.90	2.29	0.98	0.16	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.39	4.64	0.87	0.58	0.29	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.33	5.38	0.90	0.90	0.30	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	53.39	17.37	1.29	0.55	0.00	0.55	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	49.07	16.55	1.71	0.57	0.29	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	73.50	29.40	1.22	1.63	1.22	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.46	8.80	1.06	0.70	1.06	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	14.57	7.92	0.95	0.95	0.32	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.03	8.78	2.42	0.30	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.37	3.62	0.52	3.62	1.55	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.94	5.31	2.66	2.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.01	6.67	1.80	0.51	0.26	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.82	5.88	1.53	1.28	0.00	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	38.62	10.60	3.79	3.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	24.87	10.75	1.01	1.68	1.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	50.72	15.94	0.97	0.48	0.00	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	65.07	25.40	4.01	0.45	0.89	1.34	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	51.22	19.51	1.46	0.49	0.00	1.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	20.17	5.81	0.61	1.22	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	123.62	58.56	26.03	13.01	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.48	13.90	2.32	2.65	0.33	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	24.08	6.57	1.09	1.09	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.90	4.34	0.72	0.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.22	7.12	1.42	0.36	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	8.35	2.39	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	25.73	8.40	1.08	1.35	0.27	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.17	5.93	1.35	1.62	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	9.44	0.48	0.24	0.24	0.97	0.00	0.24
immature langerhans cells, donor2	11905-125F6	3.96	0.00	0.00	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	18.83	2.74	1.89	1.51	0.76	0.28	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	80.64	12.03	3.58	2.60	0.65	1.63	0.98
kidney, adult, pool1	10017-101C8	26.33	3.30	2.20	1.10	1.50	0.10	0.50
kidney, fetal, pool1	10045-101F9	9.48	2.05	1.20	0.64	0.35	0.00	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.23	4.83	2.41	1.28	1.28	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	93.73	17.56	5.81	5.11	3.73	1.38	2.07
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	55.97	13.40	2.20	1.28	1.65	0.92	0.37
left atrium, adult, donor1	10079-102A7	21.25	1.63	1.09	1.09	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	13.15	1.01	4.55	1.01	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.07	10.40	0.82	0.82	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	11.14	3.95	1.80	0.36	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	12.50	4.89	0.54	0.00	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	7.77	3.89	0.24	1.46	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	7.32	2.09	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	26.80	3.31	5.78	2.24	4.01	0.59	1.42
liposarcoma cell line:KMLS-1	10782-110G8	14.06	9.06	0.31	1.72	0.78	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	17.18	5.97	1.95	1.71	0.37	0.00	0.00
liver, adult, pool1	10018-101C9	14.42	3.40	2.76	0.81	0.97	0.16	0.49
liver, fetal, pool1	10086-102B5	15.99	0.94	0.94	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	18.67	1.60	2.33	0.58	0.87	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	20.85	1.11	3.14	1.11	0.74	0.18	0.92
locus coeruleus, adult, donor10258	10375-105G6	15.52	1.13	3.39	1.13	0.28	0.00	0.85
locus coeruleus, newborn, donor10223	10362-105F2	15.56	2.10	3.36	1.26	0.42	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	42.07	13.98	1.25	1.80	0.42	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	14.48	8.96	2.07	4.83	0.69	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.67	7.25	2.77	0.66	1.05	0.00	0.00
lung, adult, pool1	10019-101D1	10.04	2.36	1.77	0.24	0.47	0.00	0.12
lung, fetal, donor1	10068-101I5	9.99	2.28	1.14	0.86	0.29	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	20.62	2.29	2.29	0.46	0.46	0.00	0.46
lymph node, adult, donor1	10077-102A5	12.31	0.47	1.42	0.47	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	38.14	7.67	8.11	1.97	2.85	0.00	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	18.11	7.40	2.41	5.58	1.51	0.30	1.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	38.23	23.79	2.55	0.85	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	19.54	1.33	2.22	1.33	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	20.34	2.49	1.66	3.74	0.83	0.00	0.21
mature adipocyte, donor3	12233-129G1	15.17	2.61	3.32	0.47	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	14.74	1.05	4.74	1.84	2.11	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.55	10.96	2.86	1.91	1.19	0.24	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	32.71	1.13	1.13	2.26	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	22.44	2.21	1.84	0.92	2.02	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	33.67	2.86	5.08	1.91	0.95	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	38.38	4.26	4.26	0.43	1.71	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	42.53	2.03	4.05	1.35	2.19	0.17	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	28.44	2.33	1.49	0.85	1.27	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	14.35	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	24.77	2.15	1.44	0.36	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	22.07	0.65	3.89	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	19.81	2.32	2.79	1.08	1.39	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	9.55	1.39	2.12	0.82	0.24	0.08	0.00
medulla oblongata, newborn, donor10223	10361-105F1	18.75	1.74	1.39	0.35	0.69	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	23.91	7.31	6.20	1.33	0.44	0.22	1.11
medulloblastoma cell line:ONS-76	10759-110E3	40.11	4.16	2.57	1.47	0.98	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	50.89	4.17	1.01	1.29	0.29	1.15	0.14
melanoma cell line:G-361	10465-106H6	28.23	1.09	0.81	1.90	0.00	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	26.23	5.43	2.89	1.63	1.27	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	83.71	7.93	4.41	3.52	0.88	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	32.14	9.85	1.81	0.78	0.52	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	34.83	9.51	1.53	1.99	0.31	0.61	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	30.72	6.00	1.64	0.91	0.36	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	5.38	0.83	2.07	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.00	4.21	2.39	1.12	0.42	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.66	4.24	1.35	1.35	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	6.94	2.78	1.39	2.78	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.37	4.46	1.20	1.72	0.17	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.01	6.56	0.58	1.50	0.23	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.86	5.31	1.19	1.19	0.27	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.82	5.00	1.76	0.95	0.00	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.44	6.12	1.00	0.57	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.20	4.28	1.32	0.99	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.50	5.81	0.69	0.97	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.97	3.14	0.70	2.44	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.13	6.12	1.02	0.82	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.39	2.52	0.72	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.83	3.72	0.93	1.24	0.21	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.58	3.65	0.23	1.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	37.76	7.13	2.94	0.84	0.84	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	22.57	4.63	0.90	0.45	0.00	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.79	6.65	0.53	0.88	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	10.31	4.42	1.84	1.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.44	2.29	0.29	0.00	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.00	3.79	0.42	0.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.72	5.94	0.91	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.28	4.86	1.28	1.02	0.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.18	4.45	1.31	0.52	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.32	5.55	1.54	1.23	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.89	4.94	2.35	0.71	0.24	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.57	5.42	1.69	0.68	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.15	7.47	0.79	0.79	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.12	5.10	2.32	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.73	6.06	2.02	0.87	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.95	4.24	1.56	1.56	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.22	6.25	1.44	0.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	18.33	1.47	1.47	0.73	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.75	5.37	1.34	0.67	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.05	4.91	2.05	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.89	8.16	3.01	0.86	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	8.20	2.73	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	20.66	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.64	6.17	1.62	2.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	4.36	0.00	2.91	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.92	5.86	1.07	2.67	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	9.00	1.64	3.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.77	3.50	2.33	3.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	4.20	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	0.99	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	9.53	0.00	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.67	7.71	2.37	1.19	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	4.87	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	5.07	1.90	1.27	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.00	4.48	3.45	2.07	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	4.30	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	3.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	4.48	2.85	0.00	1.22	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	17.48	2.38	2.38	2.38	0.79	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	1.18	4.13	0.59	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	15.90	1.87	2.81	1.25	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	2.67	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	3.55	2.37	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	5.14	0.00	2.57	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	4.82	3.44	0.69	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.70	7.42	0.99	1.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	10.09	1.12	3.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	8.27	5.72	2.54	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	34.25	5.24	2.82	4.03	0.81	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	8.72	2.18	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	5.07	5.07	2.53	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	44.30	7.89	1.82	1.82	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	9.04	4.52	9.04	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	36.24	6.59	3.29	4.12	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.60	7.54	3.37	0.60	0.99	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.44	2.92	2.92	0.32	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	3.06	2.04	2.04	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	15.47	0.77	3.09	2.32	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	25.51	11.34	1.18	1.65	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.46	3.48	3.71	1.16	0.46	0.23	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	8.55	0.00	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	45.00	7.71	2.06	1.03	1.13	0.82	0.62
mesothelioma cell line:Mero-25	10850-111F4	27.23	5.22	3.86	1.59	1.36	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	26.65	7.82	1.47	1.47	0.98	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	18.82	2.44	1.33	1.11	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	25.23	4.47	2.89	1.31	1.58	0.79	1.31
mesothelioma cell line:Mero-83	10854-111F8	16.34	3.40	1.36	1.19	0.68	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	15.92	7.84	1.26	0.25	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	22.98	3.73	1.66	0.41	0.21	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	27.17	3.15	0.50	0.83	0.33	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	17.92	1.81	0.72	0.18	0.00	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	16.40	5.64	1.20	2.22	1.02	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	55.98	9.16	1.27	2.04	0.76	1.27	1.02
mesothelioma cell line:No36	10857-111G2	77.31	5.87	1.96	4.24	0.65	3.91	0.65
mesothelioma cell line:ONE58	10858-111G3	37.39	8.67	1.63	1.35	0.27	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	6.53	1.34	0.19	0.38	0.58	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.76	1.47	0.49	0.61	0.37	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	11.13	2.15	4.13	0.90	0.54	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	79.01	18.94	4.24	0.65	1.63	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.39	6.57	2.12	1.06	0.21	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	47.91	10.37	2.07	0.46	0.92	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.87	4.57	1.71	3.81	1.33	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	64.68	24.76	7.02	4.07	2.22	0.74	0.55
myeloma cell line:PCM6	10474-106I6	23.13	7.31	8.50	2.17	5.34	0.00	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	43.63	11.67	1.52	0.00	0.51	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	26.28	3.92	2.35	0.59	0.59	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	33.20	12.93	3.45	1.56	1.67	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	40.89	16.33	4.27	2.13	2.06	0.44	0.00
nasal epithelial cells, donor2	12227-129F4	19.87	6.62	3.31	0.55	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	50.15	16.56	5.52	2.76	0.46	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	48.83	10.85	3.37	3.37	1.31	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	70.86	8.86	2.95	1.05	1.48	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	30.00	7.83	3.54	0.75	1.12	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	68.80	28.47	1.19	0.24	0.95	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	37.22	7.76	1.27	0.95	0.32	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	33.41	11.47	3.02	0.60	2.01	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	86.46	15.89	0.00	0.64	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.17	2.93	1.60	1.06	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	12.35	1.18	8.12	12.35	2.03	0.34	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	303.39	32.02	15.21	4.00	4.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	1.92	2.89	0.32	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.18	3.42	0.53	1.58	0.79	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	16.31	2.72	2.44	1.22	0.56	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	41.21	4.12	4.12	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	22.01	0.54	2.15	1.07	0.54	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	20.38	3.64	1.46	2.55	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	39.10	2.36	4.20	1.31	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	35.19	4.72	0.86	0.86	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	12.22	1.10	1.50	0.63	0.32	0.00	0.08
olfactory region, adult	10195-103E6	20.82	0.96	2.10	1.34	0.76	0.19	0.57
optic nerve, donor1	10277-104E7	16.01	0.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	12.53	15.26	3.76	1.71	1.71	0.00	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	206.22	36.82	5.50	2.89	4.67	10.17	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	26.41	20.49	1.35	0.00	0.68	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.02	7.85	1.04	0.23	0.92	0.12	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	9.11	2.94	0.59	0.00	0.29	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.94	10.28	5.61	6.54	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	30.54	4.67	2.76	1.70	1.70	0.21	0.00
ovary, adult, pool1	10020-101D2	9.35	2.18	0.61	0.44	0.35	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.65	4.03	2.02	2.02	0.73	0.00	0.18
pancreas, adult, donor1	10049-101G4	21.63	2.82	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	33.82	8.95	0.56	1.96	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	12.10	6.64	3.07	1.02	1.02	0.00	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.50	6.79	1.32	0.83	0.17	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	21.23	2.01	1.83	1.19	0.82	0.09	0.00
parietal cortex, adult, donor10258	10373-105G4	19.08	0.73	5.87	0.73	0.73	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	31.04	2.82	3.76	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	27.65	2.28	2.28	1.43	1.14	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	16.04	2.29	2.11	1.06	0.62	0.18	0.18
parietal lobe, fetal, donor1	10072-101I9	38.79	4.85	0.97	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	25.80	5.23	2.62	1.50	0.00	0.00	0.00
parotid gland, adult	10199-103F1	17.27	4.32	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	15.04	1.61	1.61	1.61	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.57	6.51	1.30	0.56	0.37	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.74	8.60	2.77	0.87	1.60	0.29	0.44
pineal gland - adult, donor10196	10179-103C8	26.45	3.87	3.23	0.00	1.29	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	40.86	3.55	4.15	0.00	2.96	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	25.08	1.25	1.88	0.00	2.51	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	24.28	3.04	4.05	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	20.85	3.65	3.65	1.04	2.08	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	21.28	0.85	4.26	0.00	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	8.39	2.37	1.18	0.22	0.86	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	42.24	6.89	3.58	2.12	1.19	2.12	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.85	2.65	3.42	0.78	0.93	0.00	0.00
pons, adult, pool1	10033-101E6	12.14	1.89	2.24	0.34	1.29	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	16.65	2.09	1.74	0.87	1.39	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	8.37	0.00	4.18	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.91	39.04	3.35	3.79	0.58	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	20.87	6.53	2.90	2.54	1.09	0.18	0.18
prostate, adult, pool1	10022-101D4	10.79	2.00	1.54	0.36	0.73	0.00	0.00
putamen, adult, donor10196	10176-103C5	25.97	1.65	1.42	0.94	0.94	0.00	0.00
putamen, adult, donor10252	10152-102I8	49.02	3.92	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	3.28	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.67	2.17	2.17	0.97	0.48	0.24	0.24
putamen, newborn, donor10223	10365-105F5	29.24	5.25	3.00	1.50	2.25	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	17.75	14.84	1.75	2.04	0.29	0.00	0.29
rectum, fetal, donor1	10067-101I4	20.86	1.39	5.56	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	24.80	10.39	1.27	1.06	0.64	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	28.58	4.56	2.07	1.66	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	8.65	1.19	1.69	0.60	0.40	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	40.27	8.57	2.08	0.00	1.04	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.66	8.11	1.48	0.61	0.61	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.40	20.81	1.69	0.28	0.28	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	22.74	6.82	2.27	0.00	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	12.95	6.15	2.75	0.81	2.27	0.00	0.49
salivary acinar cells, donor2	11772-123I8	5.65	3.58	2.62	0.41	0.83	0.00	0.14
salivary acinar cells, donor3	11773-123I9	7.28	3.97	2.65	1.32	1.99	0.00	0.66
salivary gland, adult, pool1	10093-102C3	10.87	1.72	0.57	0.57	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	28.58	8.18	0.59	1.01	0.08	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	33.97	9.76	0.94	0.94	0.35	0.12	0.00
seminal vesicle, adult	10201-103F3	14.81	1.59	2.12	1.06	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	9.96	5.10	2.19	0.97	1.46	0.24	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.89	1.76	0.50	1.26	0.00	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	28.10	6.02	0.00	1.00	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.79	6.04	1.07	0.94	0.27	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	12.38	10.50	1.33	0.55	0.44	0.00	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	31.35	8.90	2.06	1.16	0.90	0.26	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	43.98	7.80	0.71	6.38	2.84	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	26.27	3.72	3.24	4.20	1.32	0.24	0.48
skeletal muscle, fetal, donor1	10066-101I3	11.06	2.01	1.01	0.00	1.01	0.00	1.01
skin, adult, donor1	10074-102A2	27.14	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	19.57	3.16	2.52	1.89	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	22.01	9.01	3.67	0.67	1.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.59	4.41	3.15	0.63	1.26	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	39.71	17.73	0.96	2.12	0.58	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	61.48	22.58	5.60	1.48	3.30	2.31	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	35.55	9.97	4.99	0.16	0.48	0.32	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	25.93	4.14	3.05	1.09	1.96	0.00	0.65
small intestine, adult, pool1	10024-101D6	28.55	6.21	2.63	1.19	0.84	0.00	0.24
small intestine, fetal, donor1	10064-101I1	29.97	2.95	2.46	0.98	0.98	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	20.52	8.72	3.08	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	11.89	0.78	1.29	0.52	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	20.91	6.70	1.07	0.27	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	19.27	1.15	2.29	0.46	0.92	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	18.14	1.18	2.37	0.00	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	15.22	3.46	4.84	2.08	1.38	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	18.30	3.66	2.44	1.22	1.22	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	21.12	2.30	1.38	1.84	0.92	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.19	3.73	1.05	1.05	0.75	0.15	0.00
spleen, adult, pool1	10025-101D7	12.56	2.42	2.31	1.21	0.44	0.11	0.44
spleen, fetal, pool1	10044-101F8	9.06	1.43	1.35	1.11	0.56	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	25.88	4.97	10.97	3.31	4.76	0.10	2.48
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	32.47	24.30	2.66	0.57	1.71	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	18.52	10.83	0.35	1.05	1.05	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	47.30	9.77	3.13	2.35	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	35.46	4.39	1.46	1.01	1.46	0.45	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	212.22	26.26	8.05	4.24	3.81	7.20	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	26.23	5.50	1.69	2.96	0.42	0.85	0.00
stomach, fetal, donor1	10062-101H8	27.77	3.20	2.14	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	14.24	2.85	1.14	0.57	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.15	1.87	1.66	0.83	0.83	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	22.76	2.07	4.66	1.03	1.55	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	23.32	2.83	2.83	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	54.11	15.82	2.52	1.15	0.23	0.46	0.46
temporal lobe, adult, pool1	10031-101E4	15.26	2.03	2.03	0.34	0.34	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	33.48	6.41	2.14	2.14	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	23.74	5.27	0.44	1.76	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	17.11	5.59	0.35	0.70	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	12.59	2.67	2.67	1.91	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	18.53	5.19	3.71	1.11	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	58.13	14.11	1.36	0.00	0.68	1.02	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	42.54	8.94	2.31	0.31	1.23	0.15	0.46
teratocarcinoma cell line:PA-1	10807-111A6	26.81	8.21	0.93	0.15	0.00	0.31	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	60.93	9.27	2.29	1.14	0.63	1.14	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	71.85	16.64	5.29	2.27	2.65	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	62.49	8.18	2.84	3.82	0.22	0.98	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	36.15	8.14	2.28	0.00	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	9.56	2.58	2.04	0.54	0.86	0.21	0.11
testis, adult, pool2	10096-102C6	6.77	2.26	3.16	0.00	0.45	0.00	0.45
thalamus - adult, donor10196	10168-103B6	28.70	0.00	2.21	2.21	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	22.97	1.88	1.56	0.78	1.09	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	3.08	3.08	1.54	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.85	0.99	2.14	0.66	0.82	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	20.14	1.15	2.88	1.73	0.58	1.15	0.58
throat, adult	10209-103G2	14.98	2.50	3.50	1.50	0.75	0.00	0.75
throat, fetal, donor1	10061-101H7	14.32	3.66	3.35	1.83	0.91	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	38.75	4.57	1.59	0.60	0.20	0.20	0.20
thymus, adult, pool1	10027-101D9	14.71	4.97	0.89	1.89	0.30	0.00	0.00
thymus, fetal, pool1	10043-101F7	12.88	2.81	1.04	1.66	0.73	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	26.33	5.19	2.53	1.46	0.66	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	29.06	6.29	2.10	3.07	0.84	0.00	0.00
thyroid, adult, pool1	10028-101E1	15.49	3.27	4.20	1.03	0.65	0.00	0.47
thyroid, fetal, donor1	10060-101H6	17.14	1.05	3.16	1.58	0.00	0.00	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	3.08	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	19.07	4.19	3.26	1.40	0.47	0.23	0.00
tongue, fetal, donor1	10059-101H5	31.53	3.55	6.70	3.55	1.97	0.00	0.39
tonsil, adult, pool1	10047-101G2	11.52	4.31	2.10	1.20	1.00	0.10	0.20
trachea, adult, pool1	10029-101E2	13.09	2.86	3.03	0.82	0.65	0.00	0.08
trachea, fetal, donor1	10058-101H4	17.31	3.08	2.69	1.15	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.42	4.96	2.48	1.06	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	15.30	8.11	0.71	0.61	0.30	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	15.36	15.98	6.27	1.88	1.41	0.16	0.63
tridermal teratoma cell line:HGRT	10694-109G1	43.76	13.32	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.04	12.87	3.13	1.19	1.02	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	5.80	1.37	0.85	0.17	0.00	0.17	0.17
uterus, fetal, donor1	10055-101H1	18.43	2.56	0.51	2.05	0.00	0.51	0.00
vagina, adult	10204-103F6	17.45	1.29	0.65	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	12.93	3.07	1.75	1.75	0.44	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	32.58	5.87	2.40	3.74	2.40	0.53	1.87